Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy.
about
"TRP inflammation" relationship in cardiovascular systemPredictive genomics of adverse events after cardiac surgery.Surgical biology for the clinician: vascular effects of immunosuppressionAdenovirus-mediated overexpression of glutathione-s-transferase mitigates transplant arteriosclerosis in rabbit carotid allograftsMechanisms of chronic rejection in cardiothoracic transplantation.Cardiac allograft vasculopathy: current knowledge and future direction.Coronary microvasculopathy in heart transplantation: Consequences and therapeutic implications.Immunosuppressive nano-therapeutic micelles downregulate endothelial cell inflammation and immunogenicity.Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart TransplantationDoes gender influence the likelihood or types of complications following cardiac surgery?AIP1 in graft arteriosclerosisCardiac allograft vasculopathy: a reviewRecombinant adenoviral gene transfer does not affect cardiac allograft vasculopathyMouse models for graft arteriosclerosis.Ribonuclease (RNase) Prolongs Survival of Grafts in Experimental Heart Transplantation.Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantationAttenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy.Modalities and future prospects of gene therapy in heart transplantation.Impaired Endothelial Nitric Oxide Synthase Homodimer Formation Triggers Development of Transplant Vasculopathy - Insights from a Murine Aortic Transplantation Model.Clinical utility of intravascular ultrasound in the assessment of coronary allograft vasculopathy: a review.Community-based weight management in long-term heart transplant recipients: a pilot study.Efferocytosis and Outside-In Signaling by Cardiac Phagocytes. Links to Repair, Cellular Programming, and Intercellular Crosstalk in Heart.Blood glutathione as a marker of cardiac allograft vasculopathy in heart transplant recipients.Evolving concepts and treatment strategies for cardiac allograft vasculopathy.Cardiac allograft vasculopathy after heart transplantation: Is it really ominous?Increased coronary lipid accumulation in heart transplant recipients with prior high-grade cellular rejection: novel insights from near-infrared spectroscopy.
P2860
Q26781720-0415900E-FE7D-46DD-8880-3D09F4FD84FFQ33364022-106F1706-E3E2-428E-BA68-3EE344419E67Q33604754-257FBE62-971C-4E38-AC43-5CFB85395049Q33817939-AC36C621-4380-400A-BA38-401E2EE3A522Q33841493-3C4C8BD1-EF4B-4129-AD6C-8FA3E6FCB42EQ33860323-445E9863-5AF7-4E01-8A84-46DBBB1204D7Q33891755-844275F9-8D52-4F80-9BC6-D01191A61E32Q35827879-7111EA86-C179-4D19-98D7-AFFE2AD7D61AQ35864123-2C696D1B-D3B2-42EA-8332-FD4A24CF737BQ35975701-40E94680-B989-4F74-8D56-CBCAA91AF217Q36180022-8E626DE2-42E2-486E-8436-489EC24A7370Q36252106-BCFA4B20-148E-4E70-B4A0-0E1CCA218D03Q36335977-00102BE8-D3E5-4DC5-AB84-467569A012F5Q36932950-C3669A8C-B31F-49AE-8B4D-6972A45F99FAQ36956810-689228C1-86CD-4475-AE71-BEAE362647C1Q37070435-1C63AACC-128B-466B-B3F9-CB82A2EE248EQ37121842-DB630143-DBA1-4A39-A16C-0ABC5E121738Q37422767-7A5BDEE2-59D7-498C-A617-621B2CC162FEQ37435334-63100B01-B26D-4633-8584-C04128C5F98BQ37804420-146D7434-DB72-48FD-AB2A-34D9E374AD8DQ40128297-ECE2EF36-AF14-4DA8-864D-89DA72487C01Q45341410-E4EC7765-163A-41C7-B30E-9996D19F0BC2Q46475783-E158C456-EB70-4EF5-92D7-AA0C038663ABQ47613394-9C9F1EC7-F807-41A8-A3FB-508727E3B6F3Q48170741-89435679-B7DB-4279-9BC3-A48C5E896996Q48942460-CD88D4D4-E071-4777-941C-C696AF93EAF6
P2860
Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy.
@ast
Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy.
@en
type
label
Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy.
@ast
Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy.
@en
prefLabel
Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy.
@ast
Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy.
@en
P2093
P1476
Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy.
@en
P2093
G Vassalli
L K von Segesser
L Kappenberger
W von Scheidt
Working Group Microcirculation of the Eurpean Society of Cardiology
P304
P356
10.1016/S0195-668X(03)00237-9
P577
2003-07-01T00:00:00Z